Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -17,933 | -22,698 | N/A | N/A |
| Depreciation Amortization | 208 | 345 | N/A | N/A |
| Accounts receivable | 479 | -959 | N/A | N/A |
| Accounts payable and accrued liabilities | 586 | 2,965 | N/A | N/A |
| Other Working Capital | 1,922 | 3,068 | N/A | N/A |
| Other Operating Activity | 3,710 | -1,404 | 0 | 0 |
| Operating Cash Flow | $-11,028 | $-18,682 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -293 | -124 | N/A | N/A |
| Investing Cash Flow | $-293 | $-124 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 41,241 | N/A | N/A | N/A |
| Other Financing Activity | 194 | 2,045 | 0 | 0 |
| Financing Cash Flow | $41,435 | $2,045 | $N/A | $N/A |
| Exchange Rate Effect | 1,720 | -444 | N/A | N/A |
| Beginning Cash Position | 11,432 | 28,638 | N/A | N/A |
| End Cash Position | 43,266 | 11,432 | N/A | N/A |
| Net Cash Flow | $31,834 | $-17,206 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -11,028 | -18,682 | N/A | N/A |
| Capital Expenditure | -293 | -128 | N/A | N/A |
| Free Cash Flow | -11,321 | -18,810 | 0 | 0 |